vs

Side-by-side financial comparison of RUSH ENTERPRISES INC \TX\ (RUSHA) and DENTSPLY SIRONA Inc. (XRAY). Click either name above to swap in a different company.

RUSH ENTERPRISES INC \TX\ is the larger business by last-quarter revenue ($1.7B vs $961.0M, roughly 1.8× DENTSPLY SIRONA Inc.). RUSH ENTERPRISES INC \TX\ runs the higher net margin — 3.7% vs -15.2%, a 18.9% gap on every dollar of revenue. On growth, DENTSPLY SIRONA Inc. posted the faster year-over-year revenue change (6.2% vs -9.0%). RUSH ENTERPRISES INC \TX\ produced more free cash flow last quarter ($411.6M vs $60.0M). Over the past eight quarters, DENTSPLY SIRONA Inc.'s revenue compounded faster (0.4% CAGR vs -6.8%).

Rush Enterprises is an American commercial vehicle dealership headquartered in New Braunfels, Texas. It primarily sells new and used trucks, through its Rush Truck Centers. In 2019, the company operated over 200 Rush Truck Centers in 20 U.S. states as well as 14 locations in Canada. As of 2020, it was a Fortune 500 corporation.

Dentsply Sirona Inc. is an American dental equipment manufacturer and dental consumables producer that markets its products in over 120 countries. It has factories in 21 countries. The present company is largely the result of a merger in 1993 in which Gendex Corporation acquired Dentsply International Inc. for $590 million.

RUSHA vs XRAY — Head-to-Head

Bigger by revenue
RUSHA
RUSHA
1.8× larger
RUSHA
$1.7B
$961.0M
XRAY
Growing faster (revenue YoY)
XRAY
XRAY
+15.2% gap
XRAY
6.2%
-9.0%
RUSHA
Higher net margin
RUSHA
RUSHA
18.9% more per $
RUSHA
3.7%
-15.2%
XRAY
More free cash flow
RUSHA
RUSHA
$351.6M more FCF
RUSHA
$411.6M
$60.0M
XRAY
Faster 2-yr revenue CAGR
XRAY
XRAY
Annualised
XRAY
0.4%
-6.8%
RUSHA

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
RUSHA
RUSHA
XRAY
XRAY
Revenue
$1.7B
$961.0M
Net Profit
$61.7M
$-146.0M
Gross Margin
20.4%
46.1%
Operating Margin
4.9%
-14.5%
Net Margin
3.7%
-15.2%
Revenue YoY
-9.0%
6.2%
Net Profit YoY
1.8%
66.0%
EPS (diluted)
$0.77
$-0.74

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
RUSHA
RUSHA
XRAY
XRAY
Q1 26
$1.7B
Q4 25
$1.7B
$961.0M
Q3 25
$1.8B
$904.0M
Q2 25
$1.8B
$936.0M
Q1 25
$1.8B
$879.0M
Q4 24
$1.9B
$905.0M
Q3 24
$1.8B
$951.0M
Q2 24
$1.9B
$984.0M
Net Profit
RUSHA
RUSHA
XRAY
XRAY
Q1 26
$61.7M
Q4 25
$64.3M
$-146.0M
Q3 25
$66.7M
$-427.0M
Q2 25
$72.4M
$-45.0M
Q1 25
$60.3M
$20.0M
Q4 24
$74.8M
$-430.0M
Q3 24
$79.1M
$-494.0M
Q2 24
$78.7M
$-4.0M
Gross Margin
RUSHA
RUSHA
XRAY
XRAY
Q1 26
20.4%
Q4 25
20.8%
46.1%
Q3 25
21.0%
48.8%
Q2 25
20.7%
52.4%
Q1 25
20.3%
53.0%
Q4 24
19.3%
49.3%
Q3 24
21.0%
52.1%
Q2 24
20.2%
51.9%
Operating Margin
RUSHA
RUSHA
XRAY
XRAY
Q1 26
4.9%
Q4 25
5.5%
-14.5%
Q3 25
5.6%
-24.1%
Q2 25
6.0%
-13.7%
Q1 25
5.2%
7.2%
Q4 24
5.8%
-56.2%
Q3 24
6.7%
-48.6%
Q2 24
6.4%
5.1%
Net Margin
RUSHA
RUSHA
XRAY
XRAY
Q1 26
3.7%
Q4 25
3.8%
-15.2%
Q3 25
3.7%
-47.2%
Q2 25
3.9%
-4.8%
Q1 25
3.4%
2.3%
Q4 24
3.9%
-47.5%
Q3 24
4.4%
-51.9%
Q2 24
4.1%
-0.4%
EPS (diluted)
RUSHA
RUSHA
XRAY
XRAY
Q1 26
$0.77
Q4 25
$0.81
$-0.74
Q3 25
$0.83
$-2.14
Q2 25
$0.90
$-0.22
Q1 25
$0.73
$0.10
Q4 24
$-95.13
$-2.09
Q3 24
$0.97
$-2.46
Q2 24
$97.00
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
RUSHA
RUSHA
XRAY
XRAY
Cash + ST InvestmentsLiquidity on hand
$326.0M
Total DebtLower is stronger
$277.8M
$2.3B
Stockholders' EquityBook value
$2.3B
$1.3B
Total Assets
$4.5B
$5.4B
Debt / EquityLower = less leverage
0.12×
1.70×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
RUSHA
RUSHA
XRAY
XRAY
Q1 26
Q4 25
$212.6M
$326.0M
Q3 25
$242.0M
$363.0M
Q2 25
$211.1M
$359.0M
Q1 25
$228.7M
$398.0M
Q4 24
$228.1M
$272.0M
Q3 24
$185.1M
$296.0M
Q2 24
$167.3M
$279.0M
Total Debt
RUSHA
RUSHA
XRAY
XRAY
Q1 26
$277.8M
Q4 25
$274.8M
$2.3B
Q3 25
Q2 25
Q1 25
Q4 24
$408.4M
$1.7B
Q3 24
Q2 24
Stockholders' Equity
RUSHA
RUSHA
XRAY
XRAY
Q1 26
$2.3B
Q4 25
$2.2B
$1.3B
Q3 25
$2.2B
$1.5B
Q2 25
$2.2B
$2.0B
Q1 25
$2.2B
$2.0B
Q4 24
$2.1B
$1.9B
Q3 24
$2.1B
$2.5B
Q2 24
$2.0B
$3.1B
Total Assets
RUSHA
RUSHA
XRAY
XRAY
Q1 26
$4.5B
Q4 25
$4.4B
$5.4B
Q3 25
$4.6B
$5.7B
Q2 25
$4.7B
$6.1B
Q1 25
$4.7B
$6.0B
Q4 24
$4.6B
$5.8B
Q3 24
$4.6B
$6.6B
Q2 24
$4.5B
$6.9B
Debt / Equity
RUSHA
RUSHA
XRAY
XRAY
Q1 26
0.12×
Q4 25
0.12×
1.70×
Q3 25
Q2 25
Q1 25
Q4 24
0.19×
0.90×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
RUSHA
RUSHA
XRAY
XRAY
Operating Cash FlowLast quarter
$101.0M
Free Cash FlowOCF − Capex
$411.6M
$60.0M
FCF MarginFCF / Revenue
24.4%
6.2%
Capex IntensityCapex / Revenue
2.0%
4.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$828.4M
$104.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
RUSHA
RUSHA
XRAY
XRAY
Q1 26
Q4 25
$112.9M
$101.0M
Q3 25
$367.8M
$79.0M
Q2 25
$227.6M
$48.0M
Q1 25
$153.5M
$7.0M
Q4 24
$392.3M
$87.0M
Q3 24
$111.7M
$141.0M
Q2 24
$270.6M
$208.0M
Free Cash Flow
RUSHA
RUSHA
XRAY
XRAY
Q1 26
$411.6M
Q4 25
$31.9M
$60.0M
Q3 25
$271.2M
$40.0M
Q2 25
$113.8M
$16.0M
Q1 25
$45.1M
$-12.0M
Q4 24
$263.5M
$36.0M
Q3 24
$-20.0M
$98.0M
Q2 24
$177.2M
$156.0M
FCF Margin
RUSHA
RUSHA
XRAY
XRAY
Q1 26
24.4%
Q4 25
1.9%
6.2%
Q3 25
15.2%
4.4%
Q2 25
6.2%
1.7%
Q1 25
2.6%
-1.4%
Q4 24
13.7%
4.0%
Q3 24
-1.1%
10.3%
Q2 24
9.1%
15.9%
Capex Intensity
RUSHA
RUSHA
XRAY
XRAY
Q1 26
2.0%
Q4 25
4.8%
4.3%
Q3 25
5.4%
4.3%
Q2 25
6.2%
3.4%
Q1 25
6.2%
2.2%
Q4 24
6.7%
5.6%
Q3 24
7.3%
4.5%
Q2 24
4.8%
5.3%
Cash Conversion
RUSHA
RUSHA
XRAY
XRAY
Q1 26
Q4 25
1.75×
Q3 25
5.51×
Q2 25
3.14×
Q1 25
2.55×
0.35×
Q4 24
5.25×
Q3 24
1.41×
Q2 24
3.44×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

RUSHA
RUSHA

New and used commercial vehicle sales$955.1M57%
Aftermarket products and services sales$627.2M37%
Lease and rental sales$92.3M5%
Finance and insurance$5.6M0%

XRAY
XRAY

Essential Dental Solutions$372.0M39%
Equipment And Instruments$160.0M17%
Implants And Prosthetics$150.0M16%
CADCAM$139.0M14%
Wellspect Healthcare$88.0M9%
Orthodontics$52.0M5%

Related Comparisons